The most important financial indicators for the company Novo Biomedics S.r.l. - Unique Identification Number 26839678:
sales in 2023 was
431.443
euro, registering a net profit of
132.116
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet having the NACE code 4791.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 46.0%, from 296.404 euro in the year 2022, to 431.443 euro in 2023.
The Net Profit increased by 100.186 euro, from 32.027 euro in 2022, to 132.116 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Biomedics S.r.l. - CUI 26839678
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
4.581
69.220
61.953
83.260
65.986
92.525
87.674
77.745
66.974
59.103
Current Assets
198.362
218.436
208.521
178.418
214.246
330.402
249.215
319.340
272.112
290.309
Inventories
177.849
173.748
173.559
158.917
176.694
171.343
130.440
140.133
113.740
121.012
Receivables
10.043
29.646
26.921
17.585
27.472
102.365
17.657
47.641
78.760
142.348
Cash
10.470
15.043
8.042
1.916
10.080
56.694
101.118
131.565
79.612
26.949
Shareholders Funds
2.838
-47.319
-48.236
-38.559
-11.804
71.436
178.989
287.836
322.018
313.842
Social Capital
223
225
223
219
215
211
207
202
203
202
Debts
201.302
382.775
366.127
347.335
350.953
408.711
155.962
109.060
17.068
45.089
Income in Advance
0
153
151
9.440
6.850
4.346
1.938
189
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4791 - 4791"
CAEN Financial Year
4799
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
290.309 euro in 2023 which includes Inventories of
121.012 euro, Receivables of
142.348 euro and cash availability of
26.949 euro.
The company's Equity was valued at
313.842 euro, while total Liabilities amounted to
45.089 euro.
Equity decreased by -7.199 euro, from 322.018 euro in 2022, to 313.842 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Biomedics S.r.l.